Activation of Src kinase in skeletal muscle cells by 1,25‐(OH)2‐vitamin D3 correlates with tyrosine phosphorylation of the vitamin D receptor (VDR) and VDR‐Src interaction

作者: Claudia Buitrago , Guillermo Vazquez , Ana R. De Boland , Ricardo L. Boland

DOI: 10.1002/1097-4644(20001101)79:2<274::AID-JCB100>3.0.CO;2-R

关键词:

摘要: The rapid effect of 1 alpha,25(OH(2))-vitamin D(3) [1 alpha, 25(OH(2))D(3)] on tyrosine kinase Src and its relationship to the vitamin D receptor (VDR) was investigated further characterize hormone signaling mechanism in chick muscle cells. Exposure cultured myotubes alpha,25(OH(2))D(3) caused a time-dependent increase activity, which evident at min (one-fold) reached maximum 5 (15-fold). Immunoblotting with anti-phosphotyrosine antibody immunoprecipitated showed that decreased phosphorylation state maximal effects min. Using database for protein consensus motifs we found putative site (amino acids 164-170: KTFDTTY) within primary sequence VDR. When myotube VDR it appeared onto SDS-PAGE gels as single band 58 kDa recognized by an antibody. Prior treatment cells (1)alpha,25(OH(2))D(3) significantly increased (two- three-fold above basal levels). In agreement being SH2-domain containing involved recognition tyrosine-phosphorylated targets, immunoprecipitation anti-Src under native conditions followed blotting anti-VDR antibody, or using antibodies inverse order, co-precipitates Src, thus indicating existence VDR/Src complex. Stimulation cognate ligand formation complex respect conditions. These results altogether provide first evidence date activation involving association phosphorylated

参考文章(35)
Bahiru Gametchu, Cheryl S. Watson, Shenhong Wu, Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. The FASEB Journal. ,vol. 7, pp. 1283- 1292 ,(1993) , 10.1096/FASEBJ.7.13.8405814
P.W. Jurutka, J.C. Hsieh, P.N. MacDonald, C.M. Terpening, C.A. Haussler, M.R. Haussler, G.K. Whitfield, Phosphorylation of serine 208 in the human vitamin D receptor. The predominant amino acid phosphorylated by casein kinase II, in vitro, and identification as a significant phosphorylation site in intact cells Journal of Biological Chemistry. ,vol. 268, pp. 6791- 6799 ,(1993) , 10.1016/S0021-9258(18)53319-6
Helen Piwnica-Worms, Kim B Saunders, Thomas M Roberts, Alan E Smith, Seng H Cheng, Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src Cell. ,vol. 49, pp. 75- 82 ,(1987) , 10.1016/0092-8674(87)90757-4
Ana R. De Boland, Richard L. Boland, Non-genomic signal transduction pathway of vitamin D in muscle Cellular Signalling. ,vol. 6, pp. 717- 724 ,(1994) , 10.1016/0898-6568(94)00042-5
G.G.J.M. Kuiper, A.O. Brinkmann, Steroid hormone receptor phosphorylation : is there a physiological role ? Molecular and Cellular Endocrinology. ,vol. 100, pp. 103- 107 ,(1994) , 10.1016/0303-7207(94)90287-9
J. C. Hsieh, P. W. Jurutka, M. A. Galligan, C. M. Terpening, C. A. Haussler, D. S. Samuels, Y. Shimizu, N. Shimizu, M. R. Haussler, Human vitamin D receptor is selectively phosphorylated by protein kinase C on serine 51, a residue crucial to its trans-activation function. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 88, pp. 9315- 9319 ,(1991) , 10.1073/PNAS.88.20.9315
Jack E Bodwell, Jeffrey C Webster, Christine M Jewell, John A Cidlowski, Jiong-Ming Hu, Allan Munck, Glucocorticoid receptor phosphorylation: Overview, function and cell cycle-dependence The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 65, pp. 91- 99 ,(1998) , 10.1016/S0960-0760(97)00185-4
Robert Gniadecki, Involvement of Src in the vitamin D signaling in human keratinocytes Biochemical Pharmacology. ,vol. 55, pp. 499- 503 ,(1998) , 10.1016/S0006-2952(97)00499-1
S Khare, M J Bolt, R K Wali, S F Skarosi, H K Roy, S Niedziela, B Scaglione-Sewell, B Aquino, C Abraham, M D Sitrin, T A Brasitus, M Bissonnette, 1,25 dihydroxyvitamin D3 stimulates phospholipase C-gamma in rat colonocytes: role of c-Src in PLC-gamma activation. Journal of Clinical Investigation. ,vol. 99, pp. 1831- 1841 ,(1997) , 10.1172/JCI119350